Condition: Carcinoma · Recurrent and/or Metastatic Head and Neck Squamous Cell Carcinoma · Sponsor: NATCO Pharma Ltd.
This is a Phase 2, open-label, multicenter, single-arm study of NRC-2694-A in combination with paclitaxel in patients with R/M HNSCC with progression on or after ICI therapy. A total of approximately 46 male and female patients will be enrolled. This sample size is based on Simon's 2-stage design with historical control ORR of 30% and a target ORR of 50%.
This description comes directly from the study's public registry record.
Praveen Myneni, MBBS · +91 40 23547532 · drpraveen@natcopharma.co.in
Always discuss trial participation with your own doctor first.
| Providence Medical Foundation -Fullerton | Fullerton, California, United States | Completed |
| Los Angeles Hematology Oncology Medical Group | Los Angeles, California, United States | Completed |
| Lynn Cancer Center | Boca Raton, Florida, United States | Completed |
| Miami Cancer Center | Miami, Florida, United States | Completed |
| Norton Cancer Institute - Downtown | Louisville, Kentucky, United States | Completed |
| University of Maryland Greenebaum Cancer Center | Baltimore, Maryland, United States | Completed |
| Washington University - Siteman Cancer Center | St Louis, Missouri, United States | Completed |
| Dartmouth Hitchcock Medical Center | Lebanon, New Hampshire, United States | Completed |
| Salib Oncology | Easton, Pennsylvania, United States | Completed |
| University of Wisconsin Carbone Cancer Center | Madison, Wisconsin, United States | Completed |
| Daycare Angels under AOH | Mumbai, Maharashtra, India | Recruiting |
| Grant Medical Foundation Ruby Hall Clinic | Pune, Maharashtra, India | Completed |
+ 1 more locations — full list on the registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT05283226